Tenet Healthcare (NYSE:THC) Director Sells 10,000 Shares

Key Points

• Tenet Healthcare director Richard Mark sold 10,000 shares for approximately $2.63 million, reducing his ownership by 28.47% to 25,121 shares.
• Tenet shares rose 0.4% to $264.85, near their 12-month high, while the company reported quarterly EPS of $6.12 and revenue of $6.04 billion—both above analyst expectations.
• Analyst sentiment remains strongly positive, with an average “Buy” rating and a $275.53 price target; institutional investors own 95.44% of the company.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Richard Mark sold 10,000 shares of the business's stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $263.42, for a total value of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at approximately $6,617,373.82. This trade represents a 28.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Tenet Healthcare Trading Up 0.4%

Shares of NYSE THC traded up $1.16 during trading on Monday, reaching $264.85. The company had a trading volume of 618,667 shares, compared to its average volume of 712,145. The company's fifty day moving average price is $246.18 and its 200-day moving average price is $212.44. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The stock has a market cap of $21.33 billion, a P/E ratio of 10.21, a PEG ratio of 1.01 and a beta of 1.23. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Institutional Trading of Tenet Healthcare

A number of hedge funds have recently bought and sold shares of THC. Elyxium Wealth LLC purchased a new position in Tenet Healthcare during the 4th quarter valued at about $29,000. Trust Co. of Vermont purchased a new stake in Tenet Healthcare during the 2nd quarter worth approximately $37,000. OP Asset Management Ltd acquired a new stake in shares of Tenet Healthcare during the first quarter worth $49,000. Compass Financial Management LLC purchased a new stake in Tenet Healthcare during the 2nd quarter valued at about $57,000. Finally, William B. Walkup & Associates Inc. boosted its position in Tenet Healthcare by 88.7% in the fourth quarter. William B. Walkup & Associates Inc. now owns 302 shares of the company's stock valued at $60,000 after buying an additional 142 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.

Analyst Ratings Changes

THC has been the topic of several research reports. Guggenheim upped their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a "buy" rating in a report on Tuesday, July 28th. Weiss Ratings raised Tenet Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, August 20th. Wells Fargo & Company increased their price objective on Tenet Healthcare from $231.00 to $281.00 and gave the company an "overweight" rating in a report on Monday, August 3rd. The Goldman Sachs Group restated a "buy" rating and issued a $305.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Zacks Research upgraded shares of Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $275.53.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women's health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.